| Financial Year |
March 31 2023 |
| Monetary Funds |
1,368,370,153.82 |
| Held-for-trading Financial Assets |
143,274,523.35 |
| Notes Receivable |
71,800,126.61 |
| Accounts Receivable |
646,472,096.35 |
| Advances to Suppliers |
63,742,816.92 |
| Other Receivables |
47,668,736.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,013,070,808.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,770,551.74 |
| Other Current Assets |
112,997,030.18 |
| Total Current Assets |
3,477,301,844.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
32,680,000.00 |
| Long-term Equity Investment |
298,612,667.82 |
| Investment Properties |
102,570,790.14 |
| Fixed Assetes |
2,982,887,844.17 |
| Under-construction Projects |
388,373,331.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
435,216,622.52 |
| R&D expenses |
-- |
| Goodwill |
59,636,220.58 |
| Long-Term Deferred and Prepaid Expenses |
38,142,141.45 |
| Deferred Income Tax Assets |
130,067,615.88 |
| Other Non-Current Assets |
101,602,461.88 |
| Sub-Total of Non-Current Assets |
4,624,385,492.73 |
| Total Assets |
8,101,687,337.15 |
| Short-Term Loans |
2,719,656,323.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
14,055,254.05 |
| Accounts Payable |
594,605,541.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
82,513,512.66 |
| Taxes Payable |
73,782,220.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
64,615,826.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
93,495,711.31 |
| Other Current Liabilities |
30,007,912.41 |
| Sub-Total of Current Liabilities |
3,712,679,811.23 |
| Long-term Loans |
762,291,782.36 |
| Bonds Payable |
591,702,176.15 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,979,519.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,599,962,556.68 |
| Total Liabilities |
5,312,642,367.91 |
| Paid-In Capital(Or Share Stock) |
555,560,000.00 |
| Capital Surplus |
553,633,073.71 |
| Surplus Reserve |
67,577,415.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,354,175,109.65 |
| Minority Stockholder's Interest |
219,731,717.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,569,313,251.82 |
| Owner's Equity（Stockholder's Equity） |
2,789,044,969.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,101,687,337.15 |
